F. ADDITIONAL INFORMATION:

Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance · European Union

Global Substantial Modifications; Global Interruptions and re-starts; Limitations, addressing sources of potential bias and imprecisions and Caveats; A declaration by the submitting party on the accuracy of the submitted information.

← anx_IV__cpt_5__point_4__text_1 · All articles · 1. →

Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.